Lisa A Ronald1, Jonathon R Campbell2, Caren Rose1,3, Robert Balshaw4, Kamila Romanowski1, David Z Roth1, Fawziah Marra5, Kevin Schwartzman2,6, Victoria J Cook1,7, James C Johnston1,2,3,7. 1. British Columbia Centre for Disease Control, Vancouver. 2. McGill International Tuberculosis Centre, Montreal. 3. School of Public and Population Health, University of British Columbia, Vancouver. 4. Centre for Healthcare Innovation, University of Manitoba, Winnipeg. 5. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver. 6. Respiratory Division, Montreal Chest Institute, Respiratory Epidemiology and Clinical Research Unit, McGill University, Vancouver, Canada. 7. Division of Respiratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Abstract
BACKGROUND: Latent tuberculosis infection (LTBI) screening and treatment is a key component of the World Health Organization (WHO) EndTB Strategy, but the impact of LTBI screening and treatment at a population level is unclear. We aimed to estimate the impact of LTBI screening and treatment in a population of migrants to British Columbia (BC), Canada. METHODS: This retrospective cohort included all individuals (N = 1 080 908) who immigrated to Canada as permanent residents between 1985 and 2012 and were residents in BC at any time up to 2013. Multiple administrative databases were linked to identify people with risk factors who met the WHO strong recommendations for screening: people with tuberculosis (TB) contact, with human immunodeficiency virus, on dialysis, with tumor necrosis factor-alpha inhibitors, who had an organ/haematological transplant, or with silicosis. Additional TB risk factors included immunosuppressive medications, cancer, diabetes, and migration from a country with a high TB burden. We defined active TB as preventable if diagnosed ≥6 months after a risk factor diagnosis. We estimated the number of preventable TB cases, given optimal LTBI screening and treatment, based on these risk factors. RESULTS: There were 16 085 people (1.5%) identified with WHO strong risk factors. Of the 2814 people with active TB, 118 (4.2%) were considered preventable through screening with WHO risk factors. Less than half (49.4%) were considered preventable with expanded screening to include people migrating from countries with high TB burdens, people who had been prescribed immunosuppressive medications, or people with diabetes or cancer. CONCLUSIONS: The application of WHO LTBI strong recommendations for screening would have minimally impacted the TB incidence in this population. Further high-risk groups must be identified to develop an effective LTBI screening and treatment strategy for low-incidence regions.
BACKGROUND: Latent tuberculosis infection (LTBI) screening and treatment is a key component of the World Health Organization (WHO) EndTB Strategy, but the impact of LTBI screening and treatment at a population level is unclear. We aimed to estimate the impact of LTBI screening and treatment in a population of migrants to British Columbia (BC), Canada. METHODS: This retrospective cohort included all individuals (N = 1 080 908) who immigrated to Canada as permanent residents between 1985 and 2012 and were residents in BC at any time up to 2013. Multiple administrative databases were linked to identify people with risk factors who met the WHO strong recommendations for screening: people with tuberculosis (TB) contact, with human immunodeficiency virus, on dialysis, with tumor necrosis factor-alpha inhibitors, who had an organ/haematological transplant, or with silicosis. Additional TB risk factors included immunosuppressive medications, cancer, diabetes, and migration from a country with a high TB burden. We defined active TB as preventable if diagnosed ≥6 months after a risk factor diagnosis. We estimated the number of preventable TB cases, given optimal LTBI screening and treatment, based on these risk factors. RESULTS: There were 16 085 people (1.5%) identified with WHO strong risk factors. Of the 2814 people with active TB, 118 (4.2%) were considered preventable through screening with WHO risk factors. Less than half (49.4%) were considered preventable with expanded screening to include people migrating from countries with high TB burdens, people who had been prescribed immunosuppressive medications, or people with diabetes or cancer. CONCLUSIONS: The application of WHO LTBI strong recommendations for screening would have minimally impacted the TB incidence in this population. Further high-risk groups must be identified to develop an effective LTBI screening and treatment strategy for low-incidence regions.
Authors: Sarah K Brode; Frances B Jamieson; Ryan Ng; Michael A Campitelli; Jeffrey C Kwong; J Michael Paterson; Ping Li; Alex Marchand-Austin; Claire Bombardier; Theodore K Marras Journal: Thorax Date: 2015-04-24 Impact factor: 9.139
Authors: K Lönnroth; Z Mor; C Erkens; J Bruchfeld; R R Nathavitharana; M J van der Werf; C Lange Journal: Int J Tuberc Lung Dis Date: 2017-06-01 Impact factor: 2.373
Authors: Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Linda Bauman; Karina W Davidson; John W Epling; Francisco A R García; Jessica Herzstein; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; William R Phillips; Maureen G Phipps; Michael P Pignone Journal: JAMA Date: 2016-09-06 Impact factor: 56.272
Authors: Divjot S Kumar; Lisa A Ronald; Kamila Romanowski; Caren Rose; Hennady P Shulha; Victoria J Cook; James C Johnston Journal: BMJ Open Date: 2021-03-02 Impact factor: 2.692